BML Capital Management, LLC
- SEC CIK
- 0001616824
- Latest filing
- Aug 7, 2026
ORMP holding history
Oramed Pharmaceuticals Inc. in every 13F filed by BML Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ORMP overviewAll 13F holders of ORMPFull Q2 2026 holdings
- Shares (Q2 2026)
- 866,269
- Value
- $4.17M
- % of portfolio
- 2.4%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 866,269 | $4.17M | 2.4% | −2,300,962−72.6% | Reduced | Holders |
| Q1 2026 | 3,167,231 | $10.8M | 6.9% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3,167,231 | $9.03M | 8.0% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3,167,231 | $8.36M | 7.7% | +83,978+2.7% | Added | Holders |
| Q2 2025 | 3,083,253 | $6.94M | 5.3% | +62,505+2.1% | Added | Holders |
| Q1 2025 | 3,020,748 | $6.46M | 5.2% | +376,841+14.3% | Added | Holders |
| Q4 2024 | 2,643,907 | $6.40M | 4.0% | +457,716+20.9% | Added | Holders |
| Q3 2024 | 2,186,191 | $5.33M | 3.1% | +837,153+62.1% | Added | Holders |
| Q2 2024 | 1,349,038 | $3.47M | 2.5% | +504,542+59.7% | Added | Holders |
| Q1 2024 | 844,496 | $2.47M | 1.7% | −417,063−33.1% | Reduced | Holders |
| Q4 2023 | 1,261,559 | $2.91M | 2.3% | +480,267+61.5% | Added | Holders |
| Q3 2023 | 781,292 | $2.04M | 1.9% | −68,708−8.1% | Reduced | Holders |
| Q2 2023 | 850,000 | $3.04M | 2.7% | −505,925−37.3% | Reduced | Holders |
| Q1 2023 | 1,355,925 | $2.96M | 2.6% | +1,355,925 | New | Holders |